
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CEACAM1 CRISPR/Cas9 KO Plasmid (h) | sc-417666 | 20 µg | $397.00 |
CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1) is an immunoglobulin superfamily cell-surface glycoprotein that mediates homophilic and heterophilic adhesion at epithelial and endothelial interfaces. Through its cytoplasmic ITIM motifs, CEACAM1 modulates phosphatase-dependent signaling to influence MAPK and PI3K/AKT pathway output, cytoskeletal organization, and junctional integrity. It also functions as an immune regulatory receptor on leukocytes, shaping activation thresholds and cytokine responses in inflammatory microenvironments. Dysregulated CEACAM1 expression and isoform balance have been associated with altered barrier function, immune evasion, angiogenic remodeling, and progression phenotypes across multiple solid tumors and inflammatory diseases.
CEACAM1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CEACAM1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CEACAM1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CEACAM1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CEACAM1 protein expression.
This CRISPR knockout system enables efficient generation of CEACAM1-deficient cell models for investigation of CEACAM1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.